Biotech

Beleave Announces Pre-License Inspection Date

TORONTO, ONTARIO: ...

Taconic Biosciences Announces Expansion of Key Immunodeficient Animal Model Production

HUDSON, NY: ...

Aevi Genomic Medicine Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Business Update

PHILADELPHIA, PA: ...

MEDIA ALERT: TrendMiner Presents "Introduction to Self-Service Analytics"

HOUSTON, TX: ...

Theratechnologies Acquires Commercial Rights to Ibalizumab in the European Union and Four Additional Territories

MONTREAL, QUEBEC: ...

Marina Biotech to Participate in the 29th Annual ROTH Conference

CITY OF INDUSTRY, CA: ...

Revive Therapeutics Announces Initiation of Research Discovery Program of Cannabinoid-Based Therapies Targeting Liver Diseases

TORONTO, ONTARIO: ...

Revive Therapeutics Ltd. Announces Results for the Three and Six Months Ended December 31, 2016

TORONTO, ONTARIO: ...

Arch Biopartners Closes Non-Brokered Private Placement Financing

TORONTO, ONTARIO: ...

Sermonix Pharmaceuticals Secures Worldwide Rights to Oral Lasofoxifene From Ligand Pharmaceuticals, Expanding From U.S., Japan

COLUMBUS, OH: Accord allows Sermonix to globally develop and commercialize drug for treatment of advanced breast cancer ...